Earnings Call: Q2 2023

Nov 8, 2022

Thank you very much for joining us today despite your busy schedule. On behalf of Toray Group, I would like to take this opportunity to extend my gratitude towards your continued understanding and your interest in your management and our business activities. Now, I would like to report Toray's business results for the Q2 ended September 30, 2022 and the business forecast for the fiscal year ending March 2023. Now I would like to follow the table of contents shown on Page 1. I would like to begin with a brief summary of business results for the Q2 ended September 30, 2022. Please turn to Page 3. Consolidated revenue for the 6 months period increased 18.7 percent to JPY1261.8 billion compared with the same period of the previous fiscal year. Core operating income decreased 22.5 percent to JPY54,400,000,000 and profit decreased 3% to JPY59,100,000,000. Page 4 is about special items. Special items for the 6 month period improved by JPY 20,600,000,000 to JPY 19,400,000,000 compared with the same period of the previous fiscal year, owing mainly to gain on yen 25,100,000,000 yen of revaluation of investment resulting from establishment of the joint venture. Page 5 is about assets, liabilities, equity and free cash flow. As of the end of September, assets and liabilities were affected by the increase in translated yen amounts of overseas subsidiaries because of the depreciation of the yen. Total assets stood at 3,320,900,000,000 yen an increase of 2 77,000,000,000 yen from the end of the previous fiscal year, mainly due to an increase in trade and other receivables and inventories. Total liabilities increased by JPY 116,600,000,000 to JPY160,800,000,000 compared with the end of the previous fiscal year, owing mainly to an increase in corporate bonds and borrowings. Total equity increased by JPY160,500,000,000 compared with the end of the previous fiscal year to yen160.1 billion. Owner's equity was yen 1562,000,000,000. Interest bearing liabilities was 1014,600,000,000 yen and DE ratio was 0.65 points. Free cash flow was minus at JPY28 1,000,000,000. Page 6 explains about capital expenditures, depreciation and amortization and R and D expenditures. Capital expenditures for the 6 month period increased by 1,500,000,000 yen to 42,400,000,000 yen on a year to year comparison. Depreciation and amortization increased by 3,800,000,000 yen to 64,900,000,000 yen. R and D expenditures increased by 3,400,000,000 yen to 33,000,000,000 yen compared with the same period of the previous fiscal year. This graph on Page 7 describes the factor analysis of JPY 15,800,000,000 decrease in core operating income for the 6 month period on a year to year comparison. The difference in quantity was minus 1,900,000,000 yen mainly due to decrease in sales and production accompanying the slowdown in global economic growth. The net change in price was minus 7,000,000,000 yen due to the rise in raw material prices compared with the same period of the previous fiscal year. We have been working to pass on the rise in raw material prices to the sales price, but this has not been enough to cover the price increase in raw materials and fuels. Cost variance, etcetera, was minus 9,900,000,000 yen mainly due to increases in operating expenses from increases in logistics costs and expenses related to sales activity. The chart on Page 8 shows the revenue and core operating income results by segment. Using Page 9 and after, I would like to explain the results of each segment. 1st, FibroSyntax Cells. Revenue of the overall segment increased 26.8 percent to KYF509 1,000,000,000 yen compared with the same period of the previous fiscal year. And core operating income declined 1.8 percent to yen23,900,000,000 yen Difference in quantity was positive, but the net change in price was negative due to the increase in raw material and fuel prices compared to the same period of the previous fiscal year. In addition, cost variance was negative due to the foreign cost of transportation, etcetera. Apparel applications saw a recovery from the pandemic, while hygiene material applications were sluggish as the supply demand balance worsened. The industrial applications witnessed a sluggish growth in demand due to the delay in recovery of the automobile production volume. Page 10 is the Performance Chemicals segment. Revenue increased 6.5 percent to JPY473.3 billion compared with the same period of the previous fiscal year and core operating income decreased 52 percent to JPY25,100,000,000. Difference in quantity was negative due to the slow recovery in the domestic automobile production volume, decline in demand in China and the decline in demand in the display related applications. The net change in price was also negative, although we work to proceed with passing on the rise in raw materials and fuel prices to the sales price. I would like to explain the conditions of each business on the next page. The resins business was weak given the slow recovery in the domestic automobile production volume and the decline in demand in China. On the other hand, in the chemicals business, fine chemicals performed strongly. In the films business, polyester films were affected by customers' inventory adjustment of optical applications and electronic parts. In the Electronic and Information Materials business, demand for OLED related materials and circuit materials decreased. Page 12 is the Carbon Fiber Composite Materials segment. Revenue increased 41.5% to JPY140 1,000,000,000 compared with the same period of the previous fiscal year. Core operating income was JPY 5,600,000,000, and an improvement of 9,200,000,000 yen While the segment was affected by the increase in raw material and fuel prices and the decline in the production rate of commercial aircraft in the aerospace applications, the sales of wind turbine blades and pressure vessels in the industrial applications expanded. There was also growth in the sports applications. In addition, the segment went forward with passing on the rise in raw materials and fuel prices to the sales price. I would like to explain the status of each application on the next page. In the aerospace applications, although the production rate of commercial aircraft remained at low levels, there was positive impact from the depreciation of the yen. In the sports applications, demand for bicycles, fishing rods and golf shaft applications for outdoor leisure remained strong. In terms of regular tow products among the industrial applications, sales of environment and energy related fields led by compressed natural gas tank applications expanded. As for large tow products, shipment of wind turbine blade application remains strong. Page 14, in the Environment and Engineering segment, revenue increased 23.5 percent to yen106,100,000,000 compared with the same period of the previous fiscal year and core operating income increased 35.8 percent to JPY8.3 billion. In the water treatment business, demand for reverse osmosis membranes and other products grew strongly and facilities that newly started operations contributed to the performance. In the Japanese subsidiaries, an engineering subsidiary experienced increases in the shipment of lithium ion secondary battery related equipment. Page 15 is the Life Science segment. Revenue increased 3.1 percent to 25,900,000,000 yen compared with the same period of the previous fiscal year and core operating income decreased 69% to yen 300,000,000 yen In the Pharmaceutical business, sales of pruritus treatment remitge were affected by the introduction of its generic versions as well as by NHI drug price revision. Shipment of dialyzers for hemodial filtration grew strongly in Japan, but the business was affected by the soaring process of raw materials and fuels. Page 16 business results of major subsidiaries in regions. Atore International, sales of fibers and textiles, resins and chemicals increased. Atora Engineering, the shipment of equipment for lithium ion secondary batteries increased. At our subsidiaries in Southeast Asia, a recovery trend for apparel applications was seen in the fibers and textiles market. In the industrial applications, there was impact from delay in the recovery of the automobile production. In the Performance Chemicals business, ABS resins business was affected by the decline in demand from the lockdown in China, stagnant inventory in the supply chain and by the decline in production volume of our customers in SCN's countries due to the inability to procure parts from other countries. Other subsidiaries in China, in the fibers and textiles business, demand was strong for apparel applications, although some businesses were affected by the lockdown in China and by the rise in raw materials and fuel prices. In the performance chemicals business, demand for chemical products was strong. As for our subsidiaries in the Republic of Korea, in the fibers and textiles business, sales of non woven fabrics for domestic customers increased, but was affected by the rise in raw material prices and fuel prices. The Performance Chemicals business was affected by the decrease in production volume of LCD panels for TVs and smartphones. Next, I would like to explain the consolidated business forecast for the fiscal year ending March 2023. Please turn to Page 18. The global economy, including Japan, is expected to slow down during this year due to increased inflationary pressure caused by soaring raw material and fuel prices and interest rate hikes mainly in the U. S. And Europe. In addition, China's continuation of the 0 COVID policy and the confusion in the real estate market may exert downward pressure on the global economy. Other concerns include supply restrictions caused by parts and labor shortage, prolonged Ukrainian situation and a disruption in the financial market. For the fiscal year ending March 31, 2023, Touare revised its full year consolidated forecast announced on August 9, taking into consideration its business performance for the first half of the fiscal year and the business environment. It now expects revenue of 2,600,000,000 yen, core operating income of 130,000,000,000 yen and profit of 95,000,000,000 yen. These forecasts from October onwards is based on an assumed foreign currency exchange rate of JPY 135 to the U. S. Dollar. Page 19 shows the consolidated business forecast for the fiscal year ending March 2023 by segment. Page 20 shows the comparison of core operating income between the forecast announced on August 9 and the new forecast with breakdowns in 2 segments. The factors behind the differences are shown on the right side of the table. This concludes my presentation. Thank you very much.